 |
 |
|
|
|
| Rimonabant |
 |
| White to off-white crystalline powder |
 |
| 168273-06-1 |
 |
The Rimonabant is a very great weight loss powders in nowadays markets ,and its purity is very high ,the contents is for 99%
especially for smoker and is also for patients with cardiovascular diseases
Multiple risk factors for vascular disease are associated with human endocannabinoids system, while the CB1 receptor antagonist can and with central CB1 receptors, suppress appetite, weight loss, smoking cessation, and reduce the risk of cardiovascular disease.
Rimonabant (Rimonabant) by France's sanofi aventis medical research institutions of research and development of new drugs, have to lose weight, stop smoking and Ⅱ diabetes treatment efficacy, is the world's first selective cannabinoid CB1 receptor antagonist.By selectively blocking endogenous marijuana CB1 receptors, reduce the person's appetite and addiction.
|
 |
CAS 168273-06-1 Rimonabant
Product Name:Rimonabant,Acomplia,Zimulti,Rimonabdomining Exercisesish
CAS NO:168273-06-1
Molecular Formula:C22H21Cl3N4O
Molecular Weight:463.79
Appearance:White to off-white crystalline powder
Purity:99.5%
The Rimonabant is a very great weight loss powders in nowadays markets ,and its purity is very high ,the contents is for 99%
especially for smoker and is also for patients with cardiovascular diseases
Multiple risk factors for vascular disease are associated with human endocannabinoids system, while the CB1 receptor antagonist can and with central CB1 receptors, suppress appetite, weight loss, smoking cessation, and reduce the risk of cardiovascular disease.
Rimonabant (Rimonabant) by France's sanofi aventis medical research institutions of research and development of new drugs, have to lose weight, stop smoking and Ⅱ diabetes treatment efficacy, is the world's first selective cannabinoid CB1 receptor antagonist.By selectively blocking endogenous marijuana CB1 receptors, reduce the person's appetite and addiction.
|
|
|
|
|
|
